Study Stopped
The PI is leaving MSK.
Web-based Patient Education Program to Manage Side Effects of Allogeneic Stem Cell Transplant
Developing and Assessing the Feasibility of Implementing a Video Web-based Patient Education Application
1 other identifier
interventional
N/A
1 country
1
Brief Summary
The purpose of this study is to develop an interactive web-based patient education program to help educate patients about the increased risk of MS and its cardiac risk factors following allo-SCT and to inform and motivate patients how to make lifestyle changes. This program will be used in addition to counseling at participants clinic visits. The investigators are not changing the recommendations for prevention and management of these conditions, but rather are trying to improve the way they provide this education to patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2016
CompletedFirst Submitted
Initial submission to the registry
June 20, 2016
CompletedFirst Posted
Study publicly available on registry
June 23, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2017
CompletedSeptember 14, 2016
September 1, 2016
1 year
June 20, 2016
September 13, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Percentage of patients that use the application
A successful trial will be when ≥ 50% of enrolled patients use the application.
1 year
Study Arms (1)
video web-based patient education application
EXPERIMENTALThis is a single-arm design. Development of the web-based application will occur over a 6 month period. Patient accrual will not occur until development of the program is complete. Controlled usability testing during the development/design process of the computer program will not be employed as we do not aim to assess the mechanics of patient use, but rather overall time spent interacting with the application in an uncontrolled environment. Following completion of the tool, patient accrual will occur over a six month time period in order to meet our target sample size of up to 50 participants. Participants will be directed to complete a pre-test questionnaire at the time of accrual and will have 3 months to use the program before being directed to complete the post-test questionnaire.
Interventions
Eligibility Criteria
You may qualify if:
- The option to participate will be offered to male and female allo-SCT patients at MSK ≥ 21 years of age who are greater than 90 days post-transplant and followed in or referred to the adult allo-SCT survivorship clinic at MSK
- The option to participate will be offered to male and female allo-SCT patients at MSK ≥ 21 years of age who are greater than 90 days post-transplant and disease free, but have not yet been referred to the survivorship clinic
- Able to understand written and oral English
You may not qualify if:
- Patients less than 90 days post-transplant
- Patients without internet access
- Adult post-transplant patients who have relapsed prior to study recruitment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
Related Links
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kara Mosesso, NP
Memorial Sloan Kettering Cancer Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 20, 2016
First Posted
June 23, 2016
Study Start
June 1, 2016
Primary Completion
June 1, 2017
Last Updated
September 14, 2016
Record last verified: 2016-09